Target intelligence / Profile preview

Long-chain three-finger neurotoxin (L-3FTx)

Target
L-3FTx
Molecular classification
Three-finger toxin (3FTx) family, Alpha-neurotoxin, Polypeptide
01

Overview

Long-chain three-finger neurotoxins (L-3FTxs) are a major class of potent polypeptides found in the venom of elapid snakes, including cobras, mambas, and kraits (Kini & Doley, 2010). These toxins are characterized by a structural motif consisting of three beta-sheet loops extending from a central core, stabilized by five conserved disulfide bonds (Barber et al., 2013). Their primary biological function is the high-affinity, competitive antagonism of muscle-type nicotinic acetylcholine receptors (nAChRs) at the postsynaptic membrane of the neuromuscular junction (UniProt, 2023). By blocking the binding of acetylcholine, L-3FTxs effectively halt neuromuscular transmission, leading to progressive muscle weakness, flaccid paralysis, and potentially fatal respiratory failure (WHO, 2021). In clinical practice, these toxins are the primary targets for neutralization by antivenoms, which consist of purified antibodies from immunized animals. Recent research is also focused on developing next-generation therapeutics, such as broadly neutralizing human monoclonal antibodies like 95Mat5, to improve the efficacy and safety of snakebite treatments (Khalek et al., 2024).

Other names
Type II alpha-neurotoxinLong-chain alpha-neurotoxinLong neurotoxinL-3FTX
02

Mechanism of action

Competitive antagonism of the muscle-type nicotinic acetylcholine receptor (nAChR) at the postsynaptic neuromuscular junction.

03

Biological functions

Nicotinic acetylcholine receptor antagonismNeuromuscular blockade
04

Disease associations

Snakebite envenomationNeuromuscular paralysisRespiratory failure
05

Safety considerations

Rapid onset of paralysisRespiratory arrestAntivenom-induced hypersensitivity
06

Interacting drugs

Snake antivenom

2 more in the full profile.

07

Biomarkers

Venom antigen levelsClinical neurotoxicity signs

Beyond the preview

Go deeper on Long-chain three-finger neurotoxin (L-3FTx).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long-chain three-finger neurotoxin (L-3FTx).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call